Active — Not RecruitingNot Applicable

Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives

Italy22 participantsStarted 2021-01-01

Plain-language summary

Evaluation of gut permeability and endometrial inflammasome NLRP3 in women with unexplaid recurrent pregnancy loss before-after administration of Bifidobacteriumlongum ES1.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic recurrent pregnancy loss * Genetic predisposition to celiac disease Exclusion Criteria: \-

What they're measuring

Assessment of Endometrial inflammation in RPL women

Timeframe: 3 months

Assessment of Gut permeability status in RPL women

Timeframe: 3 months

Trial details

NCT IDNCT06867900

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-05

View on ClinicalTrials.gov More Miscarriage, Recurrent trials